The NLRP3 Inflammasome Promotes Renal Inflammation and Contributes to CKD
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Inflammation significantly contributes to the progression of chronic kidney disease (CKD). Inflammasome-dependent cytokines, such as IL-1β and IL-18, play a role in CKD, but their regulation during renal injury is unknown. Here, we analyzed the processing of caspase-1, IL-1β, and IL-18 after unilateral ureteral obstruction (UUO) in mice, which suggested activation of the Nlrp3 inflammasome during renal injury. Compared with wild-type mice, Nlrp3(-/-) mice had less tubular injury, inflammation, and fibrosis after UUO, associated with a reduction in caspase-1 activation and maturation of IL-1β and IL-18; these data confirm that the Nlrp3 inflammasome upregulates these cytokines in the kidney during injury. Bone marrow chimeras revealed that Nlrp3 mediates the injurious/inflammatory processes in both hematopoietic and nonhematopoietic cellular compartments. In tissue from human renal biopsies, a wide variety of nondiabetic kidney diseases exhibited increased expression of NLRP3 mRNA, which correlated with renal function. Taken together, these results strongly support a role for NLRP3 in renal injury and identify the inflammasome as a possible therapeutic target in the treatment of patients with progressive CKD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Self-citationGout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Self-citationCryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Bauernfeind, F. G., Horvath, G., Stutz, A., Alnemri, E. S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 2,959
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
Self-citationInnate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Self-citationThe Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Self-citationAgostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Self-citationLiu, Y. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000106015.29070.e7 · Cited by 1,055
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy
Chevalier, R. L., Forbes, M. S., & Thornhill, B. A. (2009) · Kidney International · doi:10.1038/ki.2009.86 · Cited by 1,029
Cited by
Items 201–300 of 603
The role of IL-18 in type 1 diabetic nephropathy: The problem and future treatment
Elsherbiny, N. M., & Al-Gayyar, M. M. H. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.014 · Cited by 54
Wang, Y., Yu, B., Wang, L., Yang, M., Xia, Z., Wei, W., Zhang, F., & Yuan, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181248 · Cited by 51
Tumor necrosis factor-α blockade ameliorates diabetic nephropathy in rats
Cheng, D., Liang, R., Huang, B., Hou, J., Yin, J., Zhao, T., Zhou, L., Wu, R., Qian, Y., & Wang, F. (2019) · Clinical Kidney Journal · doi:10.1093/ckj/sfz137 · Cited by 51
“Second, the NLRP3 inflammasome plays a critical role in the pathogenesis and progression of DN, whereas NLRP3 deficiency ameliorates tubular injury in multiple types of renal disease [7, 8].”
BackgroundHan, S. J., Lovászi, M., Kim, M., D’Agati, V. D., Haskó, G., & Lee, H. T. (2020) · The FASEB Journal · doi:10.1096/fj.201903287r · Cited by 52
Bao, H. F., & Peng, A. (2016) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2016-0031 · Cited by 50
“First, the imbalance in ER homeostasis, as multifunctional organelle, caused disturbance of calcium homeostasis, glucose deprivation, increasing of ROS formation and oxidative stress induction[45].”
BackgroundInfluentialThe role of inflammation in cadmium nephrotoxicity: NF-κB comes into view
Hassanein, E. H. M., Mohamed, W. R., Ahmed, O. S., Abdel‐Daim, M. M., & Sayed, A. M. M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120971 · Cited by 53
Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease
Yan, Z., Wang, G., & Shi, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.785375 · Cited by 51
“In the model of unilateral ureteral obstruction, the renal tubular injury, inflammation, and fibrosis were less severe in NLRP3knockout mice (Vilaysane et al., 2010).”
BackgroundChen, H.-Y., Chiang, Y., Hong, Y.-H., Shieh, T., Huang, T., Ali, M. K., Chang, H., Wang, K.-L., & Hsia, S. (2022) · Antioxidants · doi:10.3390/antiox11112238 · Cited by 50
“Accumulating evidence supports the involvement of the NOD-like receptor family pyrin domain-containing protein 3 (NLRP3) inflammasome in driving renal fibrosis and inflammatory responses [47,48].”
BackgroundAn update on the role of the inflammasomes in the pathogenesis of kidney diseases
Darisipudi, M. N., & Knauf, F. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3153-z · Cited by 53
New Roles for Innate Immune Response in Acute and Chronic Kidney Injuries
Gonçalves, G. M., Castoldi, Â., Braga, T. T., & Câmara, N. O. S. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02523.x · Cited by 53
DAMPs in Unilateral Ureteral Obstruction
Wyczanska, M., & Lange-Sperandio, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.581300 · Cited by 51
“Accordingly, NLRP3 mice demonstrate reduced inflammation, tubular injury and fibrosis after UUO, which is associated with reduced caspase-1 activation and IL-1b and IL18 maturation (64, 65).”
BackgroundGiuliani, K. T. K., Grivei, A., Nag, P., Wang, X., Rist, M. J., Kildey, K., Law, B. M. P., Ng, M. S. Y., Wilkinson, R., Ungerer, J. P. J., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05191-z · Cited by 50
Kong, X., Zhao, Y., Wang, X., Yu, Y., Meng, Y., Yan, G., Yu, M., Jiang, L., Wu, S., Wang, B., et al. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110640 · Cited by 48
Aberrant Wound Healing in an Epidermal Interleukin-4 Transgenic Mouse Model of Atopic Dermatitis
Zhao, Y. H., Bao, L., Chan, L. S., DiPietro, L. A., & Chen, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146451 · Cited by 52
“The primers for CXCL-1, VEGF-A165, NLRP3, MMP-9, and macrophage 2 (M2) marker YM1/ Arginase 1(Arg1) were as published in [26], [19], [27], [28] and [29] respectively.”
BackgroundRomero, C. A., Remor, A. P., Latini, A., Paul, A. L. D., Torres, A. I., & Mukdsi, J. H. (2017) · Journal of Molecular Histology · doi:10.1007/s10735-017-9720-9 · Cited by 48
Regulated Cell Death Seen through the Lens of Islet Transplantation
Bruni, A. D. C., Bornstein, S. R., Linkermann, A., & Shapiro, A. M. J. (2018) · Cell Transplantation · doi:10.1177/0963689718766323 · Cited by 48
Lü, H., Yao, H., Zou, R., Chen, X., & Xu, H. (2019) · BioMed Research International · doi:10.1155/2019/3018357 · Cited by 56
“discovered that NLRP3 inflammasome activation is involved in the pathogenesis of renal inflammation [42].”
Anders, H., & Lech, M. (2013) · Kidney International · doi:10.1038/ki.2013.122 · Cited by 51
Esch, K. J., Schaut, R. G., Lamb, I. M., Clay, G. M., Lima, Á. L. M., do Nascimento, P. R. P., Whitley, E. M., Jerônimo, S. M. B., Sutterwala, F. S., Haynes, J. S., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.04.017 · Cited by 57
“Multiple studies characterize renal tubular cell secretion of IL-1b and IL-18 in response to tubulointerstitial inflammation, driving inflammation.(19,40,41) Mouse studies evaluating glomerular NLRP3 activation had conflicting results.”
BackgroundThe expanding role of the NLRP3 inflammasome from periodic fevers to therapeutic targets
Weber, A. N. R., McManus, R. M., Hornung, V., Geyer, M., Kuemmerle-Deschner, J. B., & Latz, E. (2025) · Nature Immunology · doi:10.1038/s41590-025-02230-7 · Cited by 51
Scarpioni, R., Rigante, D., Cantarini, L., Ricardi, M., Albertazzi, V., Melfa, L., & Lazzaro, A. (2014) · Clinical Rheumatology · doi:10.1007/s10067-013-2481-2 · Cited by 47
“have elegantly demonstrated that NLRP3 inflammasome regulates renal inflammation and fibrosis during ureteral obstruction in mice [21], suggesting a potential novel target for treatment of renal failure.”
BackgroundShan, Q., Zheng, G., Han, X., Wen, X., Wang, S., Li, M., Zhuang, J., Zhang, Z.-F., Hu, B., Zhang, Y., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9865495 · Cited by 47
“Nucleotide-binding oligomerization domain-like receptors (NLRs) play a vital role in innate immunity involved in some chronic kidney diseases such as diabetic nephropathy [26, 27]; NLRP3 with a pyrin domain 3, as one important component of NLRs, is a key protein of inflammasome complex consisting of NLRP3, ASC, and pr…”
BackgroundWang, S., Hong, Q., Zhang, C., Yang, Y., Cai, G., & Chen, X. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1371-1 · Cited by 48
Sehlmeyer, K., Ruwisch, J., Roldán, N., & López-Rodríguez, E. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00386 · Cited by 50
“The relevance of inflammasome activation and IL-1β signaling in fibrotic parenchyma remodeling has been shown for silica induced- ILDs (Vilaysane et al., 2010; Wree et al., 2014; Lv et al., 2018), bleomycin-induced lung fibrosis (Zhou et al., 2013) and various other organ systems (So et al., 2007; Ertunc and Hotamisli…”
BackgroundInfluentialMetabolic reprogramming heterogeneity in chronic kidney disease
Miguel, V., & Kramann, R. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13568 · Cited by 48
Astaxanthin Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis
Liu, G., Shi, Y., Peng, X., Liu, H., Peng, Y., & He, L. (2015) · Pharmacology · doi:10.1159/000381314 · Cited by 46
Boini, K. M., Xia, M., Koka, S., Gehr, T. W., & Li, P.-L. (2016) · Oncotarget · doi:10.18632/oncotarget.8023 · Cited by 45
“Recent studies from our laboratory and others demonstrated the role of inflammasome in hHcys or obesity-induced glomerular injury [5, 17, 37], acute ischemia/reperfusion-induced kidney injury [35], unilateral ureteral obstruction [38, 39] and renal biopsies from patients with non-diabetic kidney disease [36].”
BackgroundWu, C.-Y., Hua, K., Hsu, W., Suzuki, Y., Chu, L. J., Lee, Y., Takahata, A., Lee, S.-L., Wu, C., Nikolic‐Paterson, D. J., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900284 · Cited by 46
“expression is also important for full activation of the NLRP3 inflammasome (9).”
BackgroundKa, S., Chao, L. K., Lin, J., Chen, S., Li, W., Lin, C.-N., Cheng, J.-C., Jheng, H.-L., Chen, A., & Hua, K. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.003 · Cited by 45
Dapagliflozin Aggravates Renal Injury via Promoting Gluconeogenesis in db/db Mice
Jia, Y., He, J., Wang, L., Su, L., Lei, L., Huang, W., Geng, X., Zhang, S., Meng, X., Zhou, H., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487783 · Cited by 44
Role of Inflammasome in Chronic Kidney Disease
Li, L., Tang, W., & Yi, F. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8871-2_19 · Cited by 45
Yuan, X., Wang, X., Chen, C., Zhou, J., & Han, M. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0599-x · Cited by 43
“Moreover, recent evidence suggests that the NLR familypyrin domain containing 3 (NLRP3) inflammasome may upregulate cytokine production and play a critical role in renal injuries [18].”
Ding, W. Q., Liu, T., Bi, X., & Zhang, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485287 · Cited by 43
Hu, J., Wu, H., Wang, D., Yang, Z., Zhuang, L., Yang, N., & Dong, J. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.01.001 · Cited by 43
Zhou, Y., Zhu, X., Wang, X., Peng, Y., Du, J., Yin, H., Yang, H., Ni, X., & Zhang, W. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111779 · Cited by 43
Metabolic Syndrome: Is Nlrp3 Inflammasome a Trigger or a Target of Insulin Resistance?
Mori, M. A., Bézy, O., & Kahn, C. R. (2011) · Circulation Research · doi:10.1161/res.0b013e318220b57b · Cited by 44
“inflammation, and Nlrp3 inflammasome activation is observed in chronic kidney disease.(25,26)”
BackgroundRole of Uremic Toxins in Vascular Inflammation Associated with Chronic Kidney Disease
Chermiti, R., Burtey, S., & Dou, L. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237149 · Cited by 44
Diwan, V., Gobe, G. C., & Brown, L. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.007 · Cited by 42
Ding, W. Q., Xu, C., Wang, B., & Zhang, M. (2015) · Medical Science Monitor · doi:10.12659/msm.895945 · Cited by 42
“However, long-term consequences of inflammation are responsible for the development of CKD. NF-kB is a ubiquitous eukaryotic transcription factor that regulates many inflammatory cytokines.”
BackgroundInfluentialGemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome
Seo, J. B., Choi, Y., Woo, H.-I., Jung, Y.-A., Lee, S., Lee, S., Park, M., Lee, I., Jung, G., & Park, K. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0181 · Cited by 41
Hydrogen Sulfide Plays an Important Role by Influencing NLRP3 inflammasome
Wang, H., Shi, X., Qiu, M., Lv, S., Zheng, H., Niu, B., & Liu, H. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.47595 · Cited by 42
“Renal fibrosis and renal injury are important clinical features of many chronic kidney diseases (CKDS) [54].”
BackgroundMihajlovic, M., Krebber, M. M., Yang, Y., Ahmed, S., Lozovanu, V., Andreeva, D., Verhaar, M. C., & Masereeuw, R. (2021) · Biomedicines · doi:10.3390/biomedicines9101326 · Cited by 43
“We observed strong tendencies for increased NLRP3 expression in CKD kidney tissue for two different molecular bands of NLRP3 with respect to healthy tissue, similar to what was observed for other CKD models [42].”
BackgroundResultLu, M., Li, H., Liu, W., Zhang, X., Li, L., & Zhou, H. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13550 · Cited by 40
Ram, C., Gairola, S., Syed, A. M., Kulhari, U., Kundu, S., Mugale, M. N., Murty, U. S., & Sahu, B. D. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120527 · Cited by 41
Andersen, K., Eltrich, N., Lichtnekert, J., Anders, H., & Vielhauer, V. (2014) · Kidney International · doi:10.1038/ki.2014.161 · Cited by 40
Heme Induces IL-1β Secretion Through Activating NLRP3 in Kidney Inflammation
Li, Q., Fu, W., Yao, J., Ji, Z., Wang, Y., Zhou, Z., Yan, J., & Li, W. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-9823-9 · Cited by 39
“Tissue preparation was performed as previous study [21].”
MethodNovel insights into NOD-like receptors in renal diseases
Jin, J., Zhou, T.-J., Ren, G., Cai, L., & Meng, X. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00886-7 · Cited by 39
Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38/P53 signaling axis
Ganugula, R., Nuthalapati, N. K., Dwivedi, S., Zou, D., Arora, M., Friend, R., Sheikh‐Hamad, D., Basu, R., & Kumar, M. N. V. R. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.012 · Cited by 39
Xia, M., Conley, S. M., Li, G., Li, P., & Boini, K. M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000363046 · Cited by 41
Wu, H., Zhou, M., Guo, L., Yang, Z., Ji, H., & Hu, Q. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.051 · Cited by 39
de Gaetano, M., McEvoy, C. M., Andrews, D. C., Cacace, A., Hunter, J., Brennan, E. P., & Godson, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01488 · Cited by 45
IL-20 in Acute Kidney Injury: Role in Pathogenesis and Potential as a Therapeutic Target
Lin, T.-Y., & Hsu, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031009 · Cited by 41
Ullah, M., Liu, D. D., Rai, S., Concepcion, W., & Thakor, A. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114085 · Cited by 43
“Many molecular mediators of inflammation have been identified in AKI [5], which include the NLRP3 inflammasome [6], toll-like receptors (TLRs) [7], and various”
BackgroundChen, Y., Zeng, M., Zhang, Y., Guo, H., Ding, W. Q., & Sun, T. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6679100 · Cited by 41
“showed that chimeric mice harboring bone marrow-specific deletion of Nlrp3 were partly protected in a renal injury model [25].”
BackgroundRen, Y., Wang, D., Lu, F., Zou, X., Xu, L., Wang, K., Huang, W., Su, H., Zhang, C., Gao, Y., et al. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.05.019 · Cited by 38
Li, X., Zou, Y. S., Fu, Y., Xing, J., Wang, K., Wan, P., Wang, M., & Zhai, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.650283 · Cited by 38
“This finding was consistent with those of previous studies showing that the inhibition of NLRP3 inflammasome activation alleviates tubular injury in cisplatin-injected mice (Li S. et al., 2019) and that NLRP3 knockout mice exhibit attenuated UUO-induced kidney injury (Vilaysane et al., 2010).”
ResultChen, J., Wang, M.-X., Wang, M., Zhang, Y.-K., Guo, X., Chen, Y., Zhang, M.-Q., Sun, J., Liu, Y., & Liu, C. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114379 · Cited by 40
Roger, E., Chadjichristos, C. E., Kavvadas, P., Price, G. W., Cliff, C. L., Hadjadj, S., Renciot, J., Squires, P. E., & Hills, C. E. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01245-7 · Cited by 36
“Activation of the NLRP3 inflammasome and our innate immune response, is a major perpetrator of inflammatory damage in both CKD [3] and cardiovascular disease (CVD) [4], with NLRP3 activation linked to renal injuryinduced cardiac dysfunction [5].”
BackgroundC-reactive protein promotes diabetic kidney disease via Smad3-mediated NLRP3 inflammasome activation
Wang, Y., You, Y., Guo, J., Wang, J., Shao, B., Li, H.-D., Meng, X., Lan, H.-Y., & Chen, H. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.11.018 · Cited by 36
Hsu, W., Hua, K., Tuan, L., Tsai, Y., Chu, L. J., Lee, Y., Wong, W.-T., Lee, S.-L., Lai, J., Chu, C., et al. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz073 · Cited by 36
The Inflammasome in Reproductive Biology: A Promising Target for Novel Therapies
Vaccari, J. P. D. R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00008 · Cited by 37
“Since then, the inflammasome field has started to expand into other indications such as atherosclerosis (10), diabetes (11), nephropathies (12), liver diseases (13), aging (14, 15) as well as in the field of reproductive biology (16, 17), which extent even to the effects of obesity and the inflammatory contribution of…”
BackgroundZheng, T., Tan, Y., Qiu, J., Xie, Z., Hu, X., Zhang, J., & Na, N. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03751-3 · Cited by 37
Tungsanga, S., Panpetch, W., Bhunyakarnjanarat, T., Udompornpitak, K., Katavetin, P., Chancharoenthana, W., Chatthanathon, P., Somboonna, N., Tungsanga, K., Tumwasorn, S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052511 · Cited by 36
Polizio, A. H., Marino, L., Min, K.-D., Yura, Y., Rolauer, L., Cochran, J. D., Evans, M. A., Park, E., Doviak, H., Miura‐Yura, E., et al. (2024) · Circulation Research · doi:10.1161/circresaha.124.324492 · Cited by 35
“43,44 Consistently, caspase-1 activity was significantly elevated in Tet2-deficient bone marrow–derived macrophages (Figure S8A), whereas the addition of Ang II did not further increase caspase-1 activity (Figure S8B).”
Kim, K., Moon, H., Lee, Y. H., Seo, J.-W., Kim, Y., Moon, J.-Y., Kim, J. S., Jeong, K. H., Lee, T. W., Ihm, C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-54694-x · Cited by 37
Luo, B., Wang, F., Li, B., Dong, Z., Liu, X., Zhang, C., & An, F. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0600 · Cited by 36
Zhuang, Y., Zhao, F., Liang, J., Deng, X., Zhang, Y., Ding, G., Zhang, A., Jia, Z., & Huang, S. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000478070 · Cited by 35
Mehmood, A., Althobaiti, F., Zhao, L., Usman, M. A., Chen, X., Alharthi, F. R., Soliman, M. M., Shah, A. A., Murtaza, M. A., Nadeem, M., et al. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14286 · Cited by 34
Xiao, S.-Y., Lv, Y.-H., Ji, Y., Dong, Y. W., Liu, M.-C., Li, T., Cui, X., & Hu, Y. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11116-8 · Cited by 35
“NLRP3 gene-deficient mice exhibit reduced tubular injury, decreased inflammatory cell infiltration, and diminished fibrosis in a CKD model [70].”
Wang, M., Yang, L., Yang, J., & Wang, C. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2524-6 · Cited by 40
Su, Y., Wang, Y., Liu, M., & Chen, H. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12157 · Cited by 34
“The NLRP3 inflam‐ masome pathway is activated and serves a crucial role in kidney injury (25,26).”
BackgroundAspirin mediates protection from diabetic kidney disease by inducing ferroptosis inhibition
Wu, Z., Li, D., Tian, D., Liu, X., & Wu, Z. (2022) · PLoS ONE · doi:10.1371/journal.pone.0279010 · Cited by 35
A crystal-clear mechanism of chronic kidney disease
Kurts, C. (2013) · Kidney International · doi:10.1038/ki.2013.251 · Cited by 35
Chen, K., Hsu, H., Yang, H., Tian, Y., Ko, Y.-C., Yang, C.-W., & Hung, C. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.03.001 · Cited by 34
Anders, H. (2012) · Organogenesis · doi:10.4161/org.20342 · Cited by 39
Uchida, A., Kidokoro, K., Sogawa, Y., Itano, S., Nagasu, H., Satoh, M., Sasaki, T., & Kashihara, N. (2017) · Nephrology · doi:10.1111/nep.13189 · Cited by 35
“Kidney and cell lysates were prepared as described previously.(15,16) Protein samples (60–80 μg per lane) were subjected to immunoblotting analysis with antibodies against α-actin (Cell Signaling Technology, Danvers, MA, USA), β-actin (Sigma-Aldrich), GAPDH (Merck Millipore, Danvers, MA, USA), cleaved caspase-3 (Cell…”
MethodLei, X., Li, S., Luo, C., Wang, Y., Liu, Y., Xu, Z., Huang, Q., Zou, F., Chen, Y., Peng, F., et al. (2020) · Mediators of Inflammation · doi:10.1155/2020/3934769 · Cited by 34
“Therefore, inhibition of NLRP3 inflammasome activation is a new strategy for the treatment of CKD. LPS is an endotoxin that has been shown to promote activation of the NLRP3 inflammasome and increase the expression of proinflammatory cytokines such as IL-1β and IL-18 [38, 39], which is consistent with our experimental…”
BackgroundInfluentialmiRNA expression profiling regulates necroptotic cell death in hepatocellular carcinoma
Visalli, M., Bartolotta, M., Polito, F., Oteri, R., Barbera, A., Arrigo, R., Giorgio, R. M. D., Navarra, G., & Aguennouz, M. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4410 · Cited by 35
“Primers and probes were as previously reported (33,34).”
Girardi, A. C. C., Polidoro, J. Z., Castro, P. C., Pio-Abreu, A., Noronha, I. L., & Drager, L. F. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00143.2024 · Cited by 32
Zhang, L., Ding, F., Wang, R., Wu, X., Wan, Y., Hu, J., & Wu, Q. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.117082 · Cited by 32
Liu, X., Li, X., Chen, Y., Liu, X., Liu, Y., Wei, H., & Li, N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1331610 · Cited by 34
Oliveira, T. L., Schuch, R. A., Inda, G. R., Roloff, B. C., Neto, A. C. P. S., Amaral, M. G., Dellagostin, O. A., & Hartwig, D. D. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.03.078 · Cited by 32
Anti-hyperuricemic and nephroprotective effect of geniposide in chronic hyperuricemia mice
Liu, C., Zhou, H.-N., Zhang, R., Wang, X., He, S., Zhang, J., Guo, X., Wang, Q., & Sun, J. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.05.011 · Cited by 33
Ling, L., Yang, M., Ding, W. Q., & Gu, Y. (2019) · Europe PMC (PubMed Central) · Cited by 32
Arrhythmias in Chronic Kidney Disease
Akhtar, Z., Leung, L. W. M., Kontogiannis, C., Chung, I., Waleed, K. B., & Gallagher, M. M. (2022) · European Cardiology Review · doi:10.15420/ecr.2021.52 · Cited by 35
Inflammasomes in the Pathophysiology of Kidney Diseases
Masood, H., Che, R., & Zhang, A. (2015) · Kidney Diseases · doi:10.1159/000438843 · Cited by 33
Low molecular weight fucoidan protects renal tubular cells from injury induced by albumin overload
Jia, Y., Sun, Y. X., Weng, L., Li, Y., Zhang, Q., Zhou, H., & Yang, B. (2016) · Scientific Reports · doi:10.1038/srep31759 · Cited by 31
Self-citationIkeda, Y., Horinouchi, Y., Hamano, H., Hirayama, T., Kishi, S., Izawa‐Ishizawa, Y., Imanishi, M., Zamami, Y., Takechi, K., Miyamoto, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11089-0 · Cited by 31
P2X7 receptor antagonism ameliorates renal dysfunction in a rat model of sepsis
Arulkumaran, N., Sixma, M. L., Pollen, S., Ceravola, E., Jentho, E., Prendecki, M. F., Bass, P. S., Tam, F. W. K., Unwin, R. J., & Singer, M. (2018) · Physiological Reports · doi:10.14814/phy2.13622 · Cited by 33
“In a murine model of UUO, use of bone marrow chimeras revealed that NLRP3 mediates injurious/inflammatory processes in both hematopoietic and nonhematopoietic cellular compartments (Vilaysane et al. 2010).”
BackgroundWu, M. T., Li, R., Hou, Y., Song, S., Han, W., Chen, N., Du, Y., Ren, Y., & Shi, Y. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0078-8 · Cited by 31
“Semiquantitative analysis of the NLRP3, ASC, and caspase-1 p10 (c) and cleaved IL-1β and IL-18 (d) from the Western blot data. e Renal mRNA levels of NLRP3, ASC, and caspase-1 were detected by real-time PCR.”
InfluentialMandrup-Poulsen, T. R. (2013) · Dermatologic Clinics · doi:10.1016/j.det.2013.04.006 · Cited by 34
Ding, L., Liu, D., Xu, M., Liu, H., Wu, M., Tang, R., Lv, L., Ma, K., & Liu, B. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.66 · Cited by 31
Pigment Nephropathy: Novel Insights into Inflammasome-Mediated Pathogenesis
Giuliani, K. T. K., Kassianos, A. J., Healy, H. G., & Gois, P. H. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081997 · Cited by 30
“Abbreviations AKI Acute Kidney Injury ASC Apoptosis-associated speck-like protein containing a CARD domain ATP Adenosine Triphosphate CARD Caspase activation and recruitment domain CD Cluster of differentiation CKD Chronic Kidney Disease DAMPs Damage-associated molecular patterns DC Dendritic cells DKD Diabetic kidney…”
BackgroundInfluentialZhou, Z., Ying, C., Zhou, X., Shi, Y., Xu, J., Zhu, Y., Wang, M., Li, Y., Li, X., & Xiang, J. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111934 · Cited by 30
Self-citationFanelli, C., Arias, S. C. A., Machado, F. G., Okuma, J. K., Malheiros, D. M. A. C., de Azevedo, H. F. Z., Moreira‐Filho, C. A., Câmara, N. O. S., Fujihara, C. K., & Zatz, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-02915-6 · Cited by 34
Dunton, C. L., Purves, J. T., Hughes, F. M., Jin, H., & Nagatomi, J. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-1948-0 · Cited by 31
Nowak, K. L., & Chonchol, M. (2025) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2025.06.019 · Cited by 30
Melatonin prevents sepsis-induced renal injury via the PINK1/Parkin1 signaling pathway
Dai, W., Huang, H., Si, L., Hu, S., Zhou, L., Xu, L., & Deng, Y. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4306 · Cited by 32
“Similarly, several systemic conditions involving the kidneys, including hypoxia, chronic kidney disease, sepsis, glomerulonephritis, ischemia-reperfusion (I-R) injury, unilateral ureteral obstruction (UUO), crystal nephropathy and glycerol-induced renal failure (4-11), are associated with activation of the NLRP3 IL-1β…”
BackgroundLow androgen status inhibits erectile function by increasing pyroptosis in rat corpus cavernosum
Chen, Z., Li, G., Lin, H., Jiang, J., & Jiang, R. (2021) · Andrology · doi:10.1111/andr.12995 · Cited by 32
Sabra, M. S., Hemida, F. K., & Allam, E. A. H. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03427-4 · Cited by 30
“For patients with �brosis, it may be possible to predict that the NLRP3 in�ammasome will be involved in the management of renal failure (Ke et al., 2018, Vilaysane et al., 2010, Zhang and Wang, 2020).”
Background
Metadata
- Authors
- Vilaysane, A., Chun, J., Seamone, M. E., Wang, W., Chin, R., Hirota, S., Li, Y., Clark, S. A., Tschopp, J., Trpkov, K., Hemmelgarn, B. R., Beck, P. L., & Muruve, D. A.
- Affiliations
- University of Calgary (CA)
- Corresponding author
- Vilaysane, Akosua
- Chun, Justin
- Seamone, Mark E.
- Wang, Wenjie
- Chin, Rick
- Hirota, Simon
- Li, Yan
- Clark, Sharon A.
- Hemmelgarn, Brenda R.
- Beck, Paul L.
- Muruve, Daniel A.
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2010-10
- Volume
- 21
- Issue
- 10
- Pages
- 1732-1744
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC3013544
- OpenAlex
- W2111994713
- Cited by
- 587
- References
- 44
- Citations by year
- 2026: 30 · 2025: 44 · 2024: 48 · 2023: 40 · 2022: 50 · 2021: 42 · 2020: 43 · 2019: 42 · 2018: 46 · 2017: 36 · 2016: 44 · 2015: 29 · 2014: 36 · 2013: 26 · 2012: 16
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- NLRP3 inflammasome, chronic kidney disease, renal inflammation, caspase-1, IL-1β, IL-18, unilateral ureteral obstruction, renal tubular injury, renal fibrosis, non-diabetic kidney disease, therapeutic target
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Cells, Cultured, Fibrosis, Humans, Kidney, Male, Mice, Inbred C57BL, Nephritis, RNA, Messenger, Ureteral Obstruction, Mice, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.